Israel China Biotechnology (ICB) Ltd (ICB) — Financial Flexibility Index
Israel China Biotechnology (ICB) Ltd (ICB) has a Financial Flexibility Index of -0.26x as of June 2021. Free cash flow of ILA-1.06 Million (operating CF ILA-1.06 Million minus capex ILA0.00) represents 0% of total liabilities (ILA4.11 Million). Also explore Israel China Biotechnology (ICB) Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Israel China Biotechnology (ICB) Ltd Financial Flexibility Index (2015–2020)
Historical Financial Flexibility Index trend for Israel China Biotechnology (ICB) Ltd across 6 annual periods. Check how strategically is Israel China Biotechnology (ICB) Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Israel China Biotechnology (ICB) Ltd (2015–2020)
Year-by-year free cash flow to debt coverage for Israel China Biotechnology (ICB) Ltd. For the full company profile including market capitalisation, see market value of Israel China Biotechnology (ICB) Ltd.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2020 | -0.55x | ILA-4.33 Million | ILA-4.34 Million | ILA7.87 Million | ▼ -26.2% |
| 2019 | -0.44x | ILA-4.22 Million | ILA-4.22 Million | ILA9.68 Million | ▲ +75.8% |
| 2018 | -1.80x | ILA-4.43 Million | ILA-4.75 Million | ILA2.46 Million | ▼ -81.1% |
| 2017 | -0.99x | ILA-2.85 Million | ILA-3.17 Million | ILA2.87 Million | ▲ +45.7% |
| 2016 | -1.83x | ILA-3.94 Million | ILA-3.94 Million | ILA2.15 Million | ▼ -16.3% |
| 2015 | -1.58x | ILA-3.77 Million | ILA-3.81 Million | ILA2.39 Million | — |